pilocarpine has been researched along with Chronic Primary Open Angle Glaucoma in 192 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the trabecular outflow by the response to topical pilocarpine administration in patients with and without prior glaucoma filtering surgery." | 9.34 | Comparing the trabecular outflow by the response to topical pilocarpine in patients with and without glaucoma filtering surgery. ( Gulati, V; Masoumpour, M; Razeghinejad, R; Sanvicente, C; Ustaoglu, M, 2020) |
| "This study aimed to compare the safety and effect on intraocular pressure (IOP) of latanoprost given every evening versus pilocarpine/timolol maleate fixed combination (PTFC) given twice daily in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH)." | 9.13 | Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. ( Czechowicz-Janicka, K; Kałuzny, BJ; Kałuzny, J; Kecik, D; Sobecki, R; Stewart, JA; Stewart, WC, 2008) |
| "These findings suggest that latanoprost decreases ACD in patients with glaucoma or ocular hypertension after 1 month of treatment." | 9.12 | Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. ( Bolivar, G; Gutiérrez-Ortiz, C; Teus, MA, 2006) |
| "005% administered once daily with that of pilocarpine 2% administered three times daily in patients with primary open-angle glaucoma or ocular hypertension currently on monotherapy with timolol 0." | 9.09 | The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group. ( Diestelhorst, M, 2000) |
| "The authors compared the efficacy of apraclonidine 1% versus pilocarpine 4% prophylaxis of post-argon laser trabeculoplasty (ALT) intraocular pressure (IOP) spike." | 9.09 | Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty. ( Birt, CM; Chung, HS; Glover, BK; Hughes, BA; Juzych, MS; Kim, C; Ren, J; Shin, DH, 1999) |
| "To study any interaction between pilocarpine and latanoprost when administered together, and to determine the optimal timing of dosage to maximize reduction of intraocular pressure (IOP)." | 9.09 | Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. ( Crosson, CE; Hebert, RL; Kent, AR; Thomas, TJ; Vroman, DT, 1999) |
| "To compare intraocular pressure (IOP) after adding either latanoprost or pilocarpine to timolol treatment or switching to latanoprost monotherapy in glaucomatous eyes in which IOP was inadequately controlled with timolol." | 9.09 | Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group. ( Bucci, MG, 1999) |
| "Efficacy and safety of ready to use eye drops 2% carteolol-2% pilocarpine combination proved to be comparable to that of eye drops to be reconstituted in the treatment of ocular hypertension poorly controlled by beta-blocker eye drops alone." | 9.08 | [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. ( Charlin, JF; Cohn, H; Dascotte, JC; George, JL; Lesure, P; Massin, G; Massin, M; Maurin, JF; Renard, JP; Sirbat, D, 1995) |
| "To report the results of two studies on the use of dorzolamide as adjunctive therapy to timolol in patients with elevated intraocular pressure (IOP)." | 9.08 | The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. ( Clineschmidt, CM; Strahlman, ER; Tipping, R; Vogel, R, 1996) |
| "Corneal thickness measurements and endothelial cell counts were carried out in 34 patients undergoing treatment for glaucoma with 4% pilocarpine gel between 18 to 78 months after initiation of therapy." | 9.07 | Long-term effects of glaucoma therapy with 4% pilocarpine gel on corneal clarity and endothelial cell density. ( Hitchings, RA; Nagasubramanian, S; Stewart, RH, 1994) |
| "Lower response of aqueous outflow pathway structures after pilocarpine could be observed in primary open angle glaucoma (POAG) patients, which is likely to be helpful for understanding intraocular pressure (IOP) evaluation in glaucoma." | 8.31 | Changes to Outflow Structures After Pilocarpine in Primary Open Angle Glaucoma Compared With Healthy Individuals Using Optical Coherence Tomography. ( Chen, L; Chen, W; Chen, Z; Deng, C; Wang, J; Zhang, H, 2023) |
| "Objective of this study was to evaluate the intraocular pressure-reducing effect of latanoprost as monotherapy after replacing current dual therapy in glaucoma patients." | 7.71 | Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma. ( Bojić, L; Mandić, Z; Novak-Laus, K; Sarić, D, 2002) |
| "Our research studies transitory myopia induced by Pilocarpine treatment in glaucoma patients." | 7.70 | [A myopia study of glaucoma patients following pilocarpine instillation]. ( Ban, C; Hanciu, D; Petroi, C; Pop, I, 2000) |
| "To determine the incidence of intraocular pressure (IOP) rise of varying degrees after laser peripheral iridotomy (LPI) in patients with and without glaucoma treated perioperatively with pilocarpine and apraclonidine." | 7.70 | The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine. ( Gangnon, R; Heatley, GA; Kaufman, PL; Lewis, R; Perkins, TW, 1998) |
| "In 20 patients with open-angle glaucoma in aphakia or pseudophakia whose intraocular pressure had remained uncontrolled on their current medical therapy, the medication was changed from pilocarpine or carbachol to echothiophate iodide." | 7.68 | Intraocular pressure response to the replacement of pilocarpine or carbachol with echothiophate. ( Reichert, RW; Shields, MB, 1991) |
| "Thirty patients with ocular hypertension or open-angle glaucoma were tested to see if, and to what extent, guanethidine/dipivefrin and pilocarpine produced a supplementary reduction in intraocular pressure." | 7.67 | [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. ( Dausch, D; Ober, M; Scharrer, A, 1987) |
| "Eight patients with chronic open-angle glaucoma who had an intraocular pressure greater than 24 mm Hg at some time during the day while taking timolol 0." | 7.67 | Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%. ( Binkowitz, B; Maclure, GM; Sturm, A; Vogel, R, 1989) |
| "A prospective study was conducted in 30 eyes of 30 patients to determine if pilocarpine would prevent increased intraocular pressure following Q-switched neodymium (Nd):YAG laser posterior capsulotomy." | 7.67 | Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium: YAG laser posterior capsulotomy. ( Belcher, CD; Brown, SV; Simmons, RJ; Thomas, JV, 1985) |
| "Many patients with glaucoma or ocular hypertension initially receive beta-blocker monotherapy to control intraocular pressure (IOP), but some of these patients will require an additional IOP-lowering agent within 1 year." | 6.69 | Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension. ( Gormley, GJ; Hartenbaum, D; Liss, C; Maloney, S; Vaccarelli, L; Wilson, H, 1999) |
| "4% pilocarpine was compared with that of timolol 0." | 6.66 | Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study. ( Aasved, H; Høvding, G, 1987) |
| "To compare the trabecular outflow by the response to topical pilocarpine administration in patients with and without prior glaucoma filtering surgery." | 5.34 | Comparing the trabecular outflow by the response to topical pilocarpine in patients with and without glaucoma filtering surgery. ( Gulati, V; Masoumpour, M; Razeghinejad, R; Sanvicente, C; Ustaoglu, M, 2020) |
| "This study aimed to compare the safety and effect on intraocular pressure (IOP) of latanoprost given every evening versus pilocarpine/timolol maleate fixed combination (PTFC) given twice daily in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH)." | 5.13 | Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. ( Czechowicz-Janicka, K; Kałuzny, BJ; Kałuzny, J; Kecik, D; Sobecki, R; Stewart, JA; Stewart, WC, 2008) |
| "Three hundred forty consecutive patients with a new diagnosis of POAG or OH, or previously treated only with a beta-blocker and after an appropriate washout period, were treated with latanoprost for 1 month and then divided into three groups on the basis of the reduction in intraocular pressure (IOP): nonresponders (<15%), responders (> or =15% but <30%), and high-responders (> or =30%)." | 5.12 | An evaluation of the rate of nonresponders to latanoprost therapy. ( Carassa, R; Gandolfi, S; Manni, G; Marchini, G; Mastropasqua, L; Montanari, P; Orzalesi, N; Quaranta, L; Ratiglia, R; Rossetti, L; Traverso, C; Uva, M, 2006) |
| "These findings suggest that latanoprost decreases ACD in patients with glaucoma or ocular hypertension after 1 month of treatment." | 5.12 | Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. ( Bolivar, G; Gutiérrez-Ortiz, C; Teus, MA, 2006) |
| "The timolol-dorzolamide combination increases the end diastolic velocity in central retinal artery, despite a lower intraocular pressure decrease, suggesting an effect on retinal circulation." | 5.12 | The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma. ( Longo, A; Reibaldi, A; Reibaldi, M; Uva, MG, 2006) |
| "The aim of the present prospective masked study was to assess the effect of bimatoprost monotherapy on ocular blood flow and intraocular pressure (IOP) in eyes of primary chronic angle closure glaucoma patients already on concomitant timolol and pilocarpine." | 5.10 | Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma. ( Agarwal, HC; Gupta, V; Sihota, R, 2003) |
| "In eyes showing an intraocular pressure greater than 21 mm Hg upon combination therapy, the substitution of the pre-existing treatment with latanoprost can provide a significant IOP decrease." | 5.10 | Replacing maximum-tolerated medications with latanoprost versus adding latanoprost to maximum-tolerated medications: a two-center randomized prospective trial. ( Cimino, L; Gandolfi, SA; Mora, P; Orzalesi, N; Rossetti, L; Tardini, M, 2003) |
| "This study compared brimonidine with latanoprost as adjunctive therapy for the treatment of open-angle glaucoma and ocular hypertension." | 5.09 | Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group. ( Samuelson, TW; Simmons, ST, 2000) |
| "0% pilocarpine given concomitantly, and to determine patient preference, tolerability, and impact on daily life in patients with elevated intraocular pressure (IOP)." | 5.09 | The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. ( Adamsons, I; Gross, R; Pearson, J; Rusk, C; Sverrisson, T, 1999) |
| "To compare intraocular pressure (IOP) after adding either latanoprost or pilocarpine to timolol treatment or switching to latanoprost monotherapy in glaucomatous eyes in which IOP was inadequately controlled with timolol." | 5.09 | Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group. ( Bucci, MG, 1999) |
| "To study any interaction between pilocarpine and latanoprost when administered together, and to determine the optimal timing of dosage to maximize reduction of intraocular pressure (IOP)." | 5.09 | Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. ( Crosson, CE; Hebert, RL; Kent, AR; Thomas, TJ; Vroman, DT, 1999) |
| "The authors compared the efficacy of apraclonidine 1% versus pilocarpine 4% prophylaxis of post-argon laser trabeculoplasty (ALT) intraocular pressure (IOP) spike." | 5.09 | Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty. ( Birt, CM; Chung, HS; Glover, BK; Hughes, BA; Juzych, MS; Kim, C; Ren, J; Shin, DH, 1999) |
| "005% administered once daily with that of pilocarpine 2% administered three times daily in patients with primary open-angle glaucoma or ocular hypertension currently on monotherapy with timolol 0." | 5.09 | The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group. ( Diestelhorst, M, 2000) |
| "Efficacy and safety of ready to use eye drops 2% carteolol-2% pilocarpine combination proved to be comparable to that of eye drops to be reconstituted in the treatment of ocular hypertension poorly controlled by beta-blocker eye drops alone." | 5.08 | [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension]. ( Charlin, JF; Cohn, H; Dascotte, JC; George, JL; Lesure, P; Massin, G; Massin, M; Maurin, JF; Renard, JP; Sirbat, D, 1995) |
| "To report the results of two studies on the use of dorzolamide as adjunctive therapy to timolol in patients with elevated intraocular pressure (IOP)." | 5.08 | The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. ( Clineschmidt, CM; Strahlman, ER; Tipping, R; Vogel, R, 1996) |
| "The safety of dorzolamide was evaluated in patients with open-angle glaucoma or ocular hypertension over a 2-year period." | 5.08 | Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group. ( Adamsons, IA; Boyle, JE; Ostrov, CS; Polis, A, 1998) |
| " In studies 1 and 2, there was a mean reduction in intraocular pressure from a betaxolol baseline of approximately 3 to 4 mmHg." | 5.08 | Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine. ( Robin, AL, 1996) |
| "5% timolol twice daily, was conducted on 81 patients with elevated intraocular pressure (IOP)." | 5.08 | A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life. ( Adamsons, I; Snyder, E; Strohmaier, K, 1998) |
| "We studied the intraocular pressure (IOP)-lowering effect and the side effects of a new transdermal delivery system (TDS) containing pilocarpine." | 5.08 | A new transdermal delivery system for pilocarpine in glaucoma treatment. ( Diestelhorst, M; Dinslage, S; Hille, T; Otto, K, 1996) |
| "Corneal thickness measurements and endothelial cell counts were carried out in 34 patients undergoing treatment for glaucoma with 4% pilocarpine gel between 18 to 78 months after initiation of therapy." | 5.07 | Long-term effects of glaucoma therapy with 4% pilocarpine gel on corneal clarity and endothelial cell density. ( Hitchings, RA; Nagasubramanian, S; Stewart, RH, 1994) |
| "Apraclonidine and pilocarpine have been shown to be effective in reducing the incidence of intraocular pressure (IOP) spikes following argon laser trabeculoplasty." | 5.07 | Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise. ( Cunliffe, IA; Dapling, RB; Longstaff, S, 1994) |
| "Between July 1983 and January 1986, 54 patients with open-angle glaucoma or ocular hypertension were treated for 3 months with 2% pilocarpine hydrochloride (given four times daily) and one of two beta-adrenoceptor blocking drugs, levobunolol hydrochloride (0." | 5.06 | Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine. ( Batoosingh, AL; David, R; Elman, J; Masi, R; Novack, GD; Ober, M; Sears, ML, 1987) |
| "In a long-term multicenter open randomized study of 103 patients with glaucoma or intraocular hypertension, oral propranolol combined with 2% pilocarpine was compared with 0." | 5.05 | Oral and topical adrenergic beta-receptor blockers in glaucoma treatment. A multicenter study. ( Kättström, O; Mortensen, J; Ohrström, A; Polland, W; Stenström, B, 1984) |
| "A clinical comparison of an emulsion containing a new pilocarpine polymer (Polym) compound to that of a traditional pilocarpine salt solution (Plc) on the intraocular pressure (IOP) has been performed in 40 open-angle patients treated with the long acting pilocarpine-complex for 120 days." | 5.05 | [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action]. ( Andermann, C; Arne, JL; Bec, P; Mialhe, D; Vende, D, 1983) |
| "The duration of reduction in intraocular pressure after single-dose administration of three concentrations of piloplex and the vehicle of the drug was evaluated in 12 patients with open-angle glaucoma in a randomized, double-masked, crossover study." | 5.05 | A dose-response study of piloplex for duration of action. ( Duzman, E; Klein, HZ; Leon, J; Lugo, M; Shields, MB, 1985) |
| "Latanoprost, a prodrug of a prostaglandin F(2alpha) analog, is a potent ocular hypotensive agent, reducing intraocular pressure (IOP) primarily by increasing aqueous humor drainage through the uveoscleral outflow pathway." | 4.81 | Latanoprost and cholinergic agonists in combination. ( Alm, A; Camras, CB; Toris, CB, 2002) |
| "Lower response of aqueous outflow pathway structures after pilocarpine could be observed in primary open angle glaucoma (POAG) patients, which is likely to be helpful for understanding intraocular pressure (IOP) evaluation in glaucoma." | 4.31 | Changes to Outflow Structures After Pilocarpine in Primary Open Angle Glaucoma Compared With Healthy Individuals Using Optical Coherence Tomography. ( Chen, L; Chen, W; Chen, Z; Deng, C; Wang, J; Zhang, H, 2023) |
| "Objective of this study was to evaluate the intraocular pressure-reducing effect of latanoprost as monotherapy after replacing current dual therapy in glaucoma patients." | 3.71 | Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma. ( Bojić, L; Mandić, Z; Novak-Laus, K; Sarić, D, 2002) |
| "Our research studies transitory myopia induced by Pilocarpine treatment in glaucoma patients." | 3.70 | [A myopia study of glaucoma patients following pilocarpine instillation]. ( Ban, C; Hanciu, D; Petroi, C; Pop, I, 2000) |
| "To determine the incidence of intraocular pressure (IOP) rise of varying degrees after laser peripheral iridotomy (LPI) in patients with and without glaucoma treated perioperatively with pilocarpine and apraclonidine." | 3.70 | The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine. ( Gangnon, R; Heatley, GA; Kaufman, PL; Lewis, R; Perkins, TW, 1998) |
| "In 20 patients with open-angle glaucoma in aphakia or pseudophakia whose intraocular pressure had remained uncontrolled on their current medical therapy, the medication was changed from pilocarpine or carbachol to echothiophate iodide." | 3.68 | Intraocular pressure response to the replacement of pilocarpine or carbachol with echothiophate. ( Reichert, RW; Shields, MB, 1991) |
| "The influence of pilocarpine gel 4% and pilocarpine eye drops 4% or 2% on the optical and ophthalmological parameters pupil diameter, intraocular pressure, ametropia and visual acuity, range of accommodation, and nocturnal visual acuity with and without blinding was investigated." | 3.67 | [Comparative studies of pilocarpine gel and pilocarpine eyedrops]. ( Baumgart, M; Krause, K; Küchle, HJ, 1985) |
| "A 4% pilocarpine gel applied topically to eyes was evaluated in glaucomatous Beagles and normotensive Miniature Schnauzers to determine its efficacy in reducing intraocular pressure (IOP) and to assess any side effects." | 3.67 | Effects of 4% pilocarpine gel on normotensive and glaucomatous canine eyes. ( Carrier, M; Gum, GG, 1989) |
| "The effect of 5-fluorouracil (5-FU) subconjunctival injection on the bleb formation and intraocular pressure (IOP) following trabeculectomy was studied in 27 primary open-angle glaucoma patients (33 eyes) who had never been operated upon (25 eyes) or had undergone single trabeculectomy that failed to reduce IOP (8 eyes)." | 3.67 | Long-term results of 5-fluorouracil trabeculectomy for primary open-angle glaucoma. ( Kitazawa, Y; Shimizu, U; Taniguchi, T, 1989) |
| "Thirty patients with ocular hypertension or open-angle glaucoma were tested to see if, and to what extent, guanethidine/dipivefrin and pilocarpine produced a supplementary reduction in intraocular pressure." | 3.67 | [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure]. ( Dausch, D; Ober, M; Scharrer, A, 1987) |
| "A prospective study was conducted in 30 eyes of 30 patients to determine if pilocarpine would prevent increased intraocular pressure following Q-switched neodymium (Nd):YAG laser posterior capsulotomy." | 3.67 | Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium: YAG laser posterior capsulotomy. ( Belcher, CD; Brown, SV; Simmons, RJ; Thomas, JV, 1985) |
| "Eight patients with chronic open-angle glaucoma who had an intraocular pressure greater than 24 mm Hg at some time during the day while taking timolol 0." | 3.67 | Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%. ( Binkowitz, B; Maclure, GM; Sturm, A; Vogel, R, 1989) |
| "A comparative study comprising 30 patients with glaucoma and 11 ocular hypertensives showed that pilocarpine 2%-4% and metoprolol 3% lowered the intraocular pressure to the same extent over a 4-week period." | 3.66 | Metoprolol eyedrops 3%, a short-term comparison with pilocarpine and a five-month follow-up study. (Multicenter). ( Ahrendt, N; Buhl, H; Byrn, E; Nielsen, PG, 1982) |
| "From an original group of 36 Patients (15 with relatively advanced chronic open-angle glaucoma and 21 with ocular hypertension) 21 (seven glucoma and 14 ocular hypertension) were well controlled with Timolol alone or in combination with other pressure-lowering drugs after a three years' observation period." | 3.66 | [Long-term therapy with timolol for three years (author's transl)]. ( Bischoff, P; Urner-Bloch, U, 1981) |
| "A survey of the literature concerning the interaction of timolol and epinephrine in lowering intraocular pressure, and a study comparing the efficacy of timolol and dipivefrin (a prodrug of epinephrine) to that of timolol and pilocarpine are presented." | 3.66 | Combined timolol and epinephrine therapy for open angle glaucoma. ( Hurvitz, L; Knupp, JA; Mandell, AI; Shields, MB; Spaeth, GL, 1983) |
| "25% drops in twice daily dosage and does not result in any significant ocular and systemic adverse effects." | 2.70 | A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%. ( Agarwal, H; Rajashekhar, YL; Sihota, R; Venkatesh, P, 2002) |
| "Pilocarpine and timolol were not significantly different from each other and both produced a more marked pressure reduction than betaxolol." | 2.69 | A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. ( Drance, SM, 1998) |
| "Many patients with glaucoma or ocular hypertension initially receive beta-blocker monotherapy to control intraocular pressure (IOP), but some of these patients will require an additional IOP-lowering agent within 1 year." | 2.69 | Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension. ( Gormley, GJ; Hartenbaum, D; Liss, C; Maloney, S; Vaccarelli, L; Wilson, H, 1999) |
| "The single dose response of open angle glaucoma eyes to pilocarpine 1%, clonidine 0." | 2.68 | A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%. ( Agarwal, HC; Rajashekar, YL; Sihota, R, 1996) |
| "For the smaller group with simple glaucoma no significant advantage of laser could be shown." | 2.68 | Primary argon laser trabeculoplasty vs pilocarpine. III. Long-term effects on visual fields. ( Bergeå, B; Bodin, L; Svedbergh, B, 1995) |
| "In a limited group of open angle glaucoma patients treated twice daily with timoptol 0." | 2.67 | [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure]. ( Collignon-Brach, J; Leroy, C, 1990) |
| "A total of 360 patients with open angle glaucoma were included; they were defined as those who had intraocular pressure greater than 21 mm Hg while receiving single, topical antiglaucoma therapy." | 2.67 | Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. A controlled multicenter study of 48 weeks. Scandinavian Timpilo Study Group. ( Puustjärvi, TJ; Repo, LP, 1992) |
| "Intraocular pressure was consistently lower with the combination treatment than with timolol or pilocarpine alone." | 2.67 | Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma. ( Geyer, O; Krakowski, D; Lazar, M; Nemet, P; Zadok, D; Zadok, J, 1994) |
| " For timolol, nasolacrimal occlusion collapsed the dose-response curve and extended the duration of action." | 2.67 | Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion. ( Fuqua, M; Nardin, GF; Sharir, M; Zimmerman, TJ, 1992) |
| "05% dipivefrin every 12 hours might be an adequate dosage for maximal effect." | 2.67 | Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications. ( Sharir, M; Zimmerman, TJ, 1994) |
| "4% pilocarpine was compared with that obtained by 1 dose of timolol 0." | 2.67 | Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops. ( Aasved, H; Bergaust, B; Bulie, T; Høvding, G; Løfors, KT; Viksmoen, L, 1990) |
| "4% pilocarpine was compared with that of timolol 0." | 2.66 | Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study. ( Aasved, H; Høvding, G, 1987) |
| "with pilocarpine 2." | 2.65 | One-month crossover trial comparing the intraocular pressure control of 3.4% Piloplex twice daily with 2.0% pilocarpine four times daily. ( Duzman, E; Quinn, CA; Warman, A; Warman, R, 1982) |
| "Glaucoma is one of the most frequent causes of blindness in the world." | 2.45 | [Glaucoma]. ( Funk, J, 2009) |
| "Exfoliation syndrome is the most common identifiable cause leading to chronic open-angle glaucoma." | 2.39 | The impact of exfoliation syndrome on therapeutic efficacy in open-angle glaucoma. ( Hietanen, J; Tarkkanen, A, 1995) |
| "Glaucoma is a potentially blinding ocular disease that commonly affects elderly persons." | 2.37 | Glaucoma: an overview. ( Brubaker, RF; Johnson, DH, 1986) |
| "To examine the relationship of ocular hypertension (O." | 1.33 | [Ocular hypertension and glaucoma]. ( Radian, AB, 2005) |
| "Twenty cases(40 eyes) with ocular hypertension or primary open angle glaucoma(POAG) in early stage were treated by 4% PG(once per night) and PS(4 times per day)." | 1.31 | [Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma]. ( Chen, X; Liang, L; Yie, T, 2000) |
| "The author investigated 23 patients with primary open angle glaucoma treated with pilocarpine, timolol, betoptic and latanoprost." | 1.31 | [Additive effects of topical carbonic anhydrase inhibitors]. ( Potocký, M, 2001) |
| "20 patients with open angle glaucoma or ocular hypertension and an elevated intraocular pressure (IOP) over 21 mmHg and without prior oral CAI-treatment were included in this study." | 1.30 | Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. ( Barisani, T; Baumgartner, I; Biowski, R; Hommer, A; Kaminski, S; Koyuncu, D, 1998) |
| "Increasing evidence indicates that long-term use of topically administered medication can induce changes in the conjunctiva and lachrymal function." | 1.30 | Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response. ( Cerruti, A; Finazzo, C; Nuzzi, R, 1998) |
| "Topically applied 4% timolol, 4% timolol combined with 2% pilocarpine, 6% timolol, and 6% timolol combined with 2% pilocarpine were evaluated in clinically normal Beagles and Beagles with glaucoma." | 1.29 | Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma. ( Gelatt, JK; Gelatt, KN; Larocca, RD; MacKay, EO; Strubbe, DT, 1995) |
| "Twenty patients with primary open angle glaucoma who have been treated with identical antiglaucoma eye drops in both eyes were examined." | 1.29 | The effects of nasolacrimal canal blockage on topical medications for glaucoma. ( Aritürk, N; Erkan, D; Oge, I; Sahin, M; Süllü, Y, 1996) |
| "Pilocarpine is a well established topical agent, but suffers troublesome sequelae, the most apparent of which is pupillary constriction." | 1.29 | The effect of pilocarpine on the glaucomatous visual field. ( Canning, CR; Elkington, AR; Luff, AJ; Webster, AR, 1993) |
| "Fifty-four eyes of 45 patients with ocular hypertension developed early glaucomatous optic disc or visual field changes after a mean follow-up of 5." | 1.29 | Visual field prognosis in early glaucoma. A long-term clinical follow-up. ( Odberg, T, 1993) |
| "We suggest that lichen planus is a possible side effect of topical beta-blocker therapy." | 1.29 | Lichen planus associated with topical beta-blocker therapy. ( Beckman, KA; Chanes, L; Kaufman, SR, 1995) |
| "Increasing evidence indicates that long-term use of topically administered medications can induce changes in the conjunctiva and ocular surface." | 1.28 | Conjunctival impression cytology in patients with glaucoma using long-term topical medication. ( Brandt, JD; Katz, LJ; Spaeth, GL; Steinmann, WN; Wittpenn, JR, 1991) |
| "Hypothyroidism was diagnosed in a 62-year-old woman with poorly controlled primary open-angle glaucoma, including a disc hemorrhage and a documented arcuate scotoma." | 1.28 | Reversal of poorly controlled glaucoma on diagnosis and treatment of hypothyroidism. ( Allen, LH; Smith, KD; Tevaarwerk, GJ, 1992) |
| "A series of 35 patients with pigmentary glaucoma were asked to report possible side effects of topical glaucoma medication using a multiple-choice questionnaire." | 1.28 | Side effects of topical treatment in pigmentary glaucoma. ( Lehto, I, 1992) |
| "Twenty patients with untreated primary open angle glaucoma (POAG) were tested for the presence of cholinergic supersensitivity of the iris using a 0." | 1.27 | Cholinergic supersensitivity of the iris in primary open angle glaucoma. A clinical study. ( Downes, RN; Jordan, K; McCormack, PJ; Perry, SR, 1988) |
| "Pilocarpine 4% was given topically to 33 patients in order to assess its effect in preventing a pressure rise." | 1.27 | The detection and management of the acute rise in intraocular pressure following laser trabeculoplasty. ( Gillies, WE; Leung, KW, 1986) |
| "The case for an association between secondary open angle glaucoma and melanosis oculi is strengthened by our recent observation of a teenaged male with advanced glaucomatous damage in the eye with melanosis oculi." | 1.27 | Open angle glaucoma in melanosis oculi: response to laser trabeculoplasty. ( Goncalves, V; O'Donnell, FE; Sandler, T, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 67 (34.90) | 18.7374 |
| 1990's | 88 (45.83) | 18.2507 |
| 2000's | 26 (13.54) | 29.6817 |
| 2010's | 8 (4.17) | 24.3611 |
| 2020's | 3 (1.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bierlein, ER | 1 |
| Smith, JC | 1 |
| Van Hook, MJ | 1 |
| Chen, L | 1 |
| Chen, Z | 1 |
| Deng, C | 1 |
| Chen, W | 1 |
| Zhang, H | 1 |
| Wang, J | 1 |
| Ustaoglu, M | 1 |
| Masoumpour, M | 1 |
| Sanvicente, C | 1 |
| Gulati, V | 1 |
| Razeghinejad, R | 1 |
| Chen, HY | 1 |
| Lin, CL | 1 |
| Kao, CH | 1 |
| Gharbiya, M | 1 |
| Colica, C | 1 |
| Campagna, O | 1 |
| De Vico, U | 1 |
| Cruciani, F | 1 |
| Flügel-Koch, CM | 1 |
| Tektas, OY | 1 |
| Kaufman, PL | 3 |
| Paulsen, FP | 1 |
| Lütjen-Drecoll, E | 2 |
| Lin, S | 1 |
| Gupta, B | 1 |
| Rossiter, J | 1 |
| Skaat, A | 1 |
| Rosman, MS | 1 |
| Chien, JL | 1 |
| Mogil, RS | 1 |
| Ren, R | 1 |
| Liebmann, JM | 2 |
| Ritch, R | 4 |
| Park, SC | 1 |
| Zhang, L | 1 |
| Weizer, JS | 1 |
| Musch, DC | 1 |
| Kałuzny, J | 3 |
| Sobecki, R | 1 |
| Czechowicz-Janicka, K | 3 |
| Kecik, D | 1 |
| Kałuzny, BJ | 1 |
| Stewart, JA | 3 |
| Stewart, WC | 5 |
| Funk, J | 1 |
| Kim, JM | 1 |
| Park, KH | 1 |
| Kim, CY | 1 |
| Kim, HK | 1 |
| Kim, TW | 1 |
| Kim, MS | 1 |
| Burr, J | 2 |
| Azuara-Blanco, A | 2 |
| Avenell, A | 2 |
| Tuulonen, A | 2 |
| Toris, CB | 2 |
| Alm, A | 1 |
| Camras, CB | 1 |
| Diestelhorst, M | 3 |
| Nordmann, JP | 1 |
| Mandić, Z | 1 |
| Bojić, L | 1 |
| Novak-Laus, K | 1 |
| Sarić, D | 1 |
| Sihota, R | 3 |
| Rajashekhar, YL | 1 |
| Venkatesh, P | 1 |
| Agarwal, H | 1 |
| Yie, T | 1 |
| Liang, L | 1 |
| Chen, X | 1 |
| Agarwal, HC | 2 |
| Gupta, V | 1 |
| Kałuzny, JJ | 2 |
| Szaflik, J | 2 |
| Orzalkiewicz, A | 1 |
| Zaleska, A | 1 |
| Krajewska, M | 2 |
| Leech, JN | 2 |
| Gandolfi, SA | 1 |
| Rossetti, L | 2 |
| Cimino, L | 1 |
| Mora, P | 1 |
| Tardini, M | 1 |
| Orzalesi, N | 2 |
| MONTALDI, M | 1 |
| FRANGUELLI, R | 1 |
| CHANDLER, PA | 1 |
| PRATT-JOHNSON, JA | 1 |
| DRANCE, SM | 2 |
| INNES, R | 1 |
| CHANDLER, MR | 1 |
| Neelakantan, A | 1 |
| Vaishnav, HD | 1 |
| Iyer, SA | 1 |
| Sherwood, MB | 1 |
| Shah, R | 1 |
| Wormald, R | 1 |
| Orzałkiewicz, A | 1 |
| Zaleska-Zmijewska, A | 1 |
| Călugăru, M | 1 |
| Călugăru, D | 1 |
| Radian, AB | 2 |
| Uva, MG | 1 |
| Longo, A | 1 |
| Reibaldi, M | 1 |
| Reibaldi, A | 1 |
| Gandolfi, S | 1 |
| Traverso, C | 1 |
| Montanari, P | 1 |
| Uva, M | 1 |
| Manni, G | 1 |
| Carassa, R | 1 |
| Mastropasqua, L | 2 |
| Quaranta, L | 1 |
| Marchini, G | 1 |
| Ratiglia, R | 1 |
| Gutiérrez-Ortiz, C | 1 |
| Teus, MA | 2 |
| Bolivar, G | 1 |
| Strempel, I | 1 |
| Andermann, C | 1 |
| Mialhe, D | 1 |
| Arne, JL | 1 |
| Vende, D | 1 |
| Bec, P | 1 |
| O'Connor, MA | 1 |
| Mooney, DJ | 1 |
| Kass, MA | 1 |
| Meltzer, DW | 1 |
| Gordon, M | 1 |
| Ohrström, A | 1 |
| Kättström, O | 1 |
| Polland, W | 1 |
| Mortensen, J | 1 |
| Stenström, B | 1 |
| Jindra, LF | 1 |
| Remis, LL | 1 |
| Epstein, DL | 2 |
| Krieglstein, GK | 1 |
| Schrems, W | 1 |
| Hadden, OB | 1 |
| West, RH | 1 |
| Cebon, L | 1 |
| Gillies, WE | 2 |
| Gelatt, KN | 2 |
| Gum, GG | 2 |
| Brooks, DE | 1 |
| Wolf, ED | 1 |
| Bromberg, NM | 1 |
| Knupp, JA | 1 |
| Shields, MB | 5 |
| Mandell, AI | 1 |
| Hurvitz, L | 1 |
| Spaeth, GL | 2 |
| Duzman, E | 2 |
| Quinn, CA | 1 |
| Warman, A | 1 |
| Warman, R | 1 |
| Urner-Bloch, U | 1 |
| Bischoff, P | 1 |
| Granström, PA | 3 |
| Norell, S | 1 |
| Bonomi, L | 1 |
| Perfetti, S | 1 |
| Bellucci, R | 1 |
| Massa, F | 1 |
| Noya, E | 1 |
| Hung, PT | 1 |
| Hsieh, JW | 1 |
| Chiou, GC | 1 |
| Takki, KK | 1 |
| Klemetti, A | 2 |
| Valle, O | 1 |
| Nielsen, PG | 1 |
| Ahrendt, N | 1 |
| Buhl, H | 1 |
| Byrn, E | 1 |
| Kabuni, M | 1 |
| Maertens, K | 1 |
| Missotten, L | 1 |
| Zimmerman, TJ | 4 |
| Bhojwani, SC | 1 |
| Jones, DK | 1 |
| Ishikawa, T | 1 |
| Okisaka, S | 1 |
| Hiwatari, S | 1 |
| Taketani, P | 1 |
| Sugimachi, Y | 1 |
| Slavina, TM | 1 |
| Bergeå, B | 5 |
| Bodin, L | 4 |
| Svedbergh, B | 5 |
| Fraser, H | 1 |
| Beckman, KA | 1 |
| Chanes, L | 1 |
| Kaufman, SR | 1 |
| Nuzzi, R | 2 |
| Vercelli, A | 1 |
| Finazzo, C | 2 |
| Cracco, C | 1 |
| Moriarty, AP | 2 |
| Dowd, TC | 3 |
| Trimble, RB | 1 |
| Dapling, RB | 1 |
| Cunliffe, IA | 1 |
| Longstaff, S | 1 |
| Sharir, M | 3 |
| del Negro, RG | 1 |
| Ball, SF | 1 |
| Kooner, KS | 1 |
| Migdal, C | 3 |
| Gregory, W | 1 |
| Hitchings, R | 3 |
| Nagasubramanian, S | 1 |
| Stewart, RH | 1 |
| Hitchings, RA | 1 |
| Puska, P | 1 |
| Yamamoto, T | 1 |
| Chi, Q | 1 |
| Kitazawa, Y | 2 |
| Potash, SD | 1 |
| Tello, C | 1 |
| Liebmann, J | 2 |
| Odberg, T | 1 |
| Zadok, D | 1 |
| Geyer, O | 1 |
| Zadok, J | 1 |
| Lazar, M | 2 |
| Krakowski, D | 1 |
| Nemet, P | 1 |
| Claridge, KG | 1 |
| Brinchmann-Hansen, O | 1 |
| Albrektsen, T | 1 |
| Anmarkrud, N | 1 |
| Loewenstein, A | 1 |
| Webster, AR | 1 |
| Luff, AJ | 1 |
| Canning, CR | 1 |
| Elkington, AR | 1 |
| Sirbat, D | 1 |
| Charlin, JF | 1 |
| Cohn, H | 1 |
| Dascotte, JC | 1 |
| George, JL | 1 |
| Lesure, P | 1 |
| Massin, M | 1 |
| Massin, G | 1 |
| Maurin, JF | 1 |
| Renard, JP | 1 |
| Kong, L | 1 |
| Zhang, C | 1 |
| Chen, M | 1 |
| Xue, G | 1 |
| Bäcklund, M | 1 |
| Kirvelă, M | 1 |
| Lindgren, L | 1 |
| Strahlman, ER | 2 |
| Vogel, R | 3 |
| Tipping, R | 2 |
| Clineschmidt, CM | 2 |
| Carpineto, P | 1 |
| Ciancaglini, M | 1 |
| Gallenga, PE | 1 |
| Aritürk, N | 1 |
| Oge, I | 1 |
| Erkan, D | 1 |
| Süllü, Y | 1 |
| Sahin, M | 1 |
| Kushnick, H | 1 |
| Dinslage, S | 1 |
| Hille, T | 1 |
| Otto, K | 1 |
| Rajashekar, YL | 1 |
| Larocca, RD | 1 |
| Gelatt, JK | 1 |
| Strubbe, DT | 1 |
| MacKay, EO | 1 |
| Laster, SF | 1 |
| Martin, JL | 1 |
| Fleming, JB | 1 |
| Robin, AL | 2 |
| Barber, BL | 1 |
| Laibovitz, R | 1 |
| Guess, HA | 1 |
| Reines, SA | 1 |
| Sponsel, WE | 2 |
| Zetlan, SR | 1 |
| Stodtmeister, R | 2 |
| Rocchi, A | 1 |
| Tingey, D | 1 |
| Yüksel, N | 1 |
| Elibol, O | 1 |
| Caglar, Y | 1 |
| Alçelik, T | 1 |
| Castejón, MA | 1 |
| Calvo, MA | 1 |
| Fagúndez, MA | 1 |
| Sharma, A | 1 |
| Gupta, A | 1 |
| Holló, G | 1 |
| Süveges, I | 1 |
| Nagymihály, A | 1 |
| Vargha, P | 1 |
| Kaminski, S | 1 |
| Hommer, A | 1 |
| Koyuncu, D | 1 |
| Biowski, R | 1 |
| Barisani, T | 1 |
| Baumgartner, I | 1 |
| Turano, KA | 1 |
| Huang, AS | 1 |
| Quigley, HA | 1 |
| Boles Carenini, B | 1 |
| Brogliatti, B | 1 |
| Dorigo, MT | 1 |
| Vadalà, G | 1 |
| Protti, R | 1 |
| Bellone, A | 1 |
| Taverniti, L | 1 |
| Voccia, L | 1 |
| Amoroso, L | 1 |
| De Stefano, C | 1 |
| Virno, M | 1 |
| Strohmaier, K | 1 |
| Snyder, E | 1 |
| Adamsons, I | 2 |
| De Popa, DP | 1 |
| Andreescu, G | 1 |
| Albu, C | 1 |
| Lewis, R | 1 |
| Perkins, TW | 1 |
| Gangnon, R | 1 |
| Heatley, GA | 1 |
| Adamsons, IA | 1 |
| Polis, A | 1 |
| Ostrov, CS | 1 |
| Boyle, JE | 1 |
| Kalmann, R | 1 |
| Mourits, MP | 1 |
| D'Andrea, A | 1 |
| D'Andrea, D | 1 |
| Ferreri, G | 1 |
| Bucci, MG | 1 |
| Cerruti, A | 1 |
| Karpen, M | 1 |
| Tarkkanen, A | 1 |
| Hietanen, J | 1 |
| Ren, J | 1 |
| Shin, DH | 1 |
| Chung, HS | 1 |
| Birt, CM | 1 |
| Glover, BK | 1 |
| Juzych, MS | 1 |
| Hughes, BA | 1 |
| Kim, C | 1 |
| Zabala, L | 1 |
| Saldanha, C | 1 |
| Martins e Silva, J | 1 |
| Souza-Ramalho, P | 1 |
| Kent, AR | 1 |
| Vroman, DT | 1 |
| Thomas, TJ | 1 |
| Hebert, RL | 1 |
| Crosson, CE | 1 |
| Hartenbaum, D | 1 |
| Maloney, S | 1 |
| Vaccarelli, L | 1 |
| Liss, C | 1 |
| Wilson, H | 1 |
| Gormley, GJ | 1 |
| Sverrisson, T | 1 |
| Gross, R | 1 |
| Pearson, J | 1 |
| Rusk, C | 1 |
| Krupin, T | 1 |
| Simmons, ST | 1 |
| Samuelson, TW | 1 |
| Pop, I | 1 |
| Ban, C | 1 |
| Hanciu, D | 1 |
| Petroi, C | 1 |
| Konstas, AG | 1 |
| Lake, S | 1 |
| Maltezos, AC | 1 |
| Holmes, KT | 1 |
| Gottanka, J | 1 |
| Johnson, DH | 3 |
| Martus, P | 1 |
| Potocký, M | 1 |
| Mardin, CY | 1 |
| Schlötzer-Schrehardt, U | 1 |
| Naumann, GO | 1 |
| Puustjärvi, TJ | 1 |
| Repo, LP | 1 |
| Crick, RP | 2 |
| Mills, KB | 1 |
| Reynolds, PM | 1 |
| Sass, W | 1 |
| Smith, KD | 1 |
| Tevaarwerk, GJ | 1 |
| Allen, LH | 1 |
| Rebolleda, G | 1 |
| Muñoz, FJ | 1 |
| Fernández Victorio, JM | 1 |
| Pellicer, T | 1 |
| del Castillo, JM | 1 |
| Lehto, I | 1 |
| Nardin, GF | 1 |
| Fuqua, M | 1 |
| Brandt, JD | 1 |
| Wittpenn, JR | 1 |
| Katz, LJ | 1 |
| Steinmann, WN | 1 |
| Maas, S | 2 |
| Ros, FE | 2 |
| De Heer, LJ | 2 |
| De Keizer, RJ | 2 |
| Reichert, RW | 2 |
| Heath, DH | 1 |
| Sonnsjö, B | 1 |
| Holmin, C | 1 |
| Krakau, CE | 1 |
| Weseley, P | 1 |
| Cantor, LB | 1 |
| Harding, S | 1 |
| Rennie, I | 1 |
| Fernandez-Bahamonde, JL | 1 |
| Alcaraz-Michelli, V | 1 |
| Fujimoto, N | 1 |
| Adachi-Usami, E | 1 |
| Yah, LH | 1 |
| Pfeiffer, N | 1 |
| Grehn, F | 1 |
| Hennekes, R | 1 |
| Garus, H | 1 |
| Løfors, KT | 1 |
| Høvding, G | 2 |
| Viksmoen, L | 1 |
| Aasved, H | 2 |
| Bergaust, B | 1 |
| Bulie, T | 1 |
| Vymazal, M | 1 |
| Válková, Z | 1 |
| Poláchová, M | 1 |
| Dokonalová, E | 1 |
| Dragounová, H | 1 |
| Jezdinský, J | 1 |
| Leroy, C | 1 |
| Collignon-Brach, J | 1 |
| Newson, RB | 1 |
| Shipley, MJ | 1 |
| Blackmore, H | 1 |
| Bulpitt, CJ | 1 |
| Pillunat, LE | 1 |
| Söderström, MB | 1 |
| Wallin, O | 1 |
| Thorburn, W | 1 |
| Begg, IS | 1 |
| Cottle, RW | 1 |
| Koponen, J | 1 |
| Alanko, HI | 1 |
| Airaksinen, PJ | 2 |
| Carrier, M | 1 |
| Taniguchi, T | 1 |
| Shimizu, U | 1 |
| Zhaboedov, GD | 1 |
| Slavnova, AV | 1 |
| Fedirko, PA | 1 |
| Maclure, GM | 1 |
| Sturm, A | 1 |
| Binkowitz, B | 1 |
| Zhou, WB | 1 |
| Peng, DW | 1 |
| Chen, XQ | 1 |
| Zeng, SJ | 1 |
| Qiu, PX | 1 |
| Hu, BR | 1 |
| Boguszaková, J | 1 |
| Dubská, Z | 1 |
| Dientsbier, E | 1 |
| Hendl, J | 1 |
| Richards, RD | 1 |
| Scharrer, A | 2 |
| Ober, M | 3 |
| David, R | 1 |
| Masi, R | 1 |
| Elman, J | 1 |
| Novack, GD | 1 |
| Sears, ML | 1 |
| Batoosingh, AL | 1 |
| Dallas, NL | 1 |
| Hobley, AJ | 1 |
| Mroczek-Madziarowa, D | 1 |
| Smith, RJ | 1 |
| Valkonen, R | 1 |
| Stenborg, T | 1 |
| Takki, K | 1 |
| Kontkanen, M | 1 |
| Oskala, P | 1 |
| Puustjärvi, T | 1 |
| Aine, E | 1 |
| Hakala, T | 1 |
| Jordan, K | 1 |
| Perry, SR | 1 |
| McCormack, PJ | 1 |
| Downes, RN | 1 |
| Brubaker, RF | 1 |
| Dausch, D | 1 |
| Duffey, RJ | 1 |
| Ferguson, JG | 1 |
| Rossmann, H | 1 |
| Wesemann, W | 1 |
| Leung, KW | 1 |
| Littmann, L | 1 |
| Kempler, P | 1 |
| Rohla, M | 1 |
| Fenyvesi, T | 1 |
| Klein, HZ | 1 |
| Lugo, M | 1 |
| Leon, J | 1 |
| Kenyon, KR | 1 |
| Van Buskirk, EM | 1 |
| Goncalves, V | 1 |
| Sandler, T | 1 |
| O'Donnell, FE | 1 |
| Brown, SV | 1 |
| Thomas, JV | 1 |
| Belcher, CD | 1 |
| Simmons, RJ | 1 |
| Krause, K | 1 |
| Küchle, HJ | 1 |
| Baumgart, M | 1 |
| Kronfeld, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647] | 61 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug in Patients With Open Angle Early Visual Field Defects Glaucoma or Ocular Hypertension in Comparison to Xalatan © Eye Drops in the Second Eye[NCT03318146] | 40 participants (Anticipated) | Interventional | 2018-06-01 | Not yet recruiting | |||
| [NCT00000144] | Phase 3 | 0 participants | Interventional | 1984-01-31 | Completed | ||
| Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma[NCT02679482] | 36 participants (Anticipated) | Observational | 2014-09-30 | Recruiting | |||
| External Micropulse Diode Laser Transscleral Trabeculoplasty(EMDLT) For Severe Open Angle Glaucoma[NCT00443664] | Early Phase 1 | 30 participants (Anticipated) | Interventional | 2006-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for pilocarpine and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.
Topics: Adrenergic alpha-2 Receptor Agonists; Antihypertensive Agents; Brimonidine Tartrate; Clonidine; Conj | 2017 |
[Glaucoma].
Topics: Acetazolamide; Age Factors; Aged; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Diagnosis, | 2009 |
Medical versus surgical interventions for open angle glaucoma.
Topics: Aged; Glaucoma, Open-Angle; Humans; Middle Aged; Pilocarpine; Randomized Controlled Trials as Topic; | 2012 |
Latanoprost and cholinergic agonists in combination.
Topics: Antihypertensive Agents; Drug Synergism; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; In | 2002 |
Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Glaucoma, Open-Angl | 2002 |
Glaucoma.
Topics: Glaucoma; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iridectomy; L | 2003 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Dr | 2004 |
Medical versus surgical interventions for open angle glaucoma.
Topics: Aged; Glaucoma, Open-Angle; Humans; Middle Aged; Pilocarpine; Randomized Controlled Trials as Topic; | 2005 |
Treatment of glaucoma.
Topics: Betaxolol; Epinephrine; Glaucoma; Glaucoma, Open-Angle; Humans; Hydroxydopamines; Laser Therapy; Lev | 1984 |
The impact of exfoliation syndrome on therapeutic efficacy in open-angle glaucoma.
Topics: Adrenergic alpha-Agonists; Dinoprost; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocula | 1995 |
Pilocarpine and dipivefrin.
Topics: Epinephrine; Glaucoma, Open-Angle; Humans; Pilocarpine | 1991 |
Glaucoma: an overview.
Topics: Aged; Aqueous Humor; Carbonic Anhydrase Inhibitors; Cholinesterase Inhibitors; Epinephrine; Glaucoma | 1986 |
82 trials available for pilocarpine and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Comparing the trabecular outflow by the response to topical pilocarpine in patients with and without glaucoma filtering surgery.
Topics: Cross-Sectional Studies; Double-Blind Method; Filtering Surgery; Glaucoma; Glaucoma, Open-Angle; Hum | 2020 |
Effect of Pilocarpine Hydrochloride on the Schlemm Canal in Healthy Eyes and Eyes With Open-Angle Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Female; Follow-Up Studies; Glaucoma, Open-Angl | 2016 |
Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Drug Administration Schedule; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; In | 2008 |
A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Clonidine; Drug Administration Schedule; Dru | 2002 |
Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Amides; Bimatoprost; Chronic Disease; Cl | 2003 |
Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients.
Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Human | 2003 |
Replacing maximum-tolerated medications with latanoprost versus adding latanoprost to maximum-tolerated medications: a two-center randomized prospective trial.
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glau | 2003 |
[Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; | 2004 |
The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.
Topics: Aged; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Ciliary Arteries; Cross-Over Stu | 2006 |
An evaluation of the rate of nonresponders to latanoprost therapy.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Drug Resistance; Glaucoma, Open-A | 2006 |
Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Antihypertensive Agents; Female; Glaucoma, Open-An | 2006 |
Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug | 1982 |
[Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Female; Glaucoma, Open-Angle; Hu | 1983 |
The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Epinephrine; Female; | 1983 |
A miniature compliance monitor for eyedrop medication.
Topics: Aged; Clinical Trials as Topic; Electronics, Medical; Equipment Design; Female; Glaucoma, Open-Angle | 1984 |
Oral and topical adrenergic beta-receptor blockers in glaucoma treatment. A multicenter study.
Topics: Administration, Oral; Clinical Trials as Topic; Glaucoma; Glaucoma, Open-Angle; Hemodynamics; Humans | 1984 |
One-month crossover trial comparing the intraocular pressure control of 3.4% Piloplex twice daily with 2.0% pilocarpine four times daily.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug | 1982 |
Ocular hypotensive effects of N-demethylated carbachol on open angle glaucoma.
Topics: Adolescent; Adult; Aged; Carbachol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male | 1982 |
Primary argon laser trabeculoplasty vs pilocarpine. III. Long-term effects on visual fields.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Longitudinal Studie | 1995 |
Primary argon laser trabeculoplasty vs pilocarpine. IV. Long-term effects on optic nerve head.
Topics: Aged; Atrophy; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Longitudin | 1995 |
The Glaucoma Laser Trial (GLT): 6. Treatment group differences in visual field changes. Glaucoma Laser Trial Research Group.
Topics: Adult; Double-Blind Method; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pre | 1995 |
Influence of apraclonidine and pilocarpine alone and in combination on post laser trabeculoplasty pressure rise.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Blood Pressure; Clonidine; Glaucoma, Open-Angle; | 1994 |
A comparison of the efficacy of various metipranolol-pilocarpine combinations in patients with ocular hypertension and primary open-angle glaucoma.
Topics: Adult; Aged; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Glaucoma, Open | 1994 |
Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.
Topics: Aged; Chronic Disease; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure | 1994 |
Long-term effects of glaucoma therapy with 4% pilocarpine gel on corneal clarity and endothelial cell density.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthropometry; Cell Count; Child; Corneal Opacity; Endot | 1994 |
Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.
Topics: Aged; Carbachol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; E | 1994 |
Primary argon laser trabeculoplasty vs pilocarpine. II: Long-term effects on intraocular pressure and facility of outflow. Study design and additional therapy.
Topics: Aged; Aqueous Humor; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; | 1994 |
[Interaction between a prostaglandin F2 alpha derivative, UF-021, and pilocarpine in ocular hypotensive therapy].
Topics: Adult; Aged; Dinoprost; Drug Synergism; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Int | 1994 |
Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
Topics: Administration, Topical; Adult; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Int | 1994 |
Pilocarpine drops do not reduce intraocular pressure sufficiently in pseudoexfoliation glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Dis | 1993 |
[Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Double-Blind Method; Drug Combinations; Female; Glauco | 1995 |
The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chemothe | 1996 |
A new transdermal delivery system for pilocarpine in glaucoma treatment.
Topics: Absorption; Administration, Cutaneous; Administration, Topical; Aged; Aged, 80 and over; Chromatogra | 1996 |
A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressu | 1996 |
The effect of a medication alarm device on patient compliance with topical pilocarpine.
Topics: Administration, Topical; Drug Administration Schedule; Drug Packaging; Equipment and Supplies; Femal | 1996 |
Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Double-Blind Method; Drug Therapy, Combination; Female | 1996 |
Validation of a questionnaire for comparing the tolerability of ophthalmic medications.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Eye Diseases; Female; Glaucoma, Open-An | 1997 |
Retinal capillary hemodynamics and VEP/pressure tolerance: evidence of retinal microcirculatory compromise in treated glaucomatous eyes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Evoked Potentials, Visual; Female; Glau | 1997 |
Economic evaluation of dorzolamide vs. pilocarpine for primary open-angle glaucoma.
Topics: Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; Costs and Cost Analysis; Glaucoma, Ope | 1997 |
Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Clonidine; Dr | 1997 |
Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (tw
Topics: Administration, Topical; Adrenergic beta-Antagonists; Blood Pressure; Chronic Disease; Drug Therapy, | 1997 |
A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Chemothe | 1998 |
A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Hum | 1998 |
Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
Topics: Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Gl | 1998 |
Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Chronic Disease | 1998 |
Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Circadian Rhythm; Drug Therapy, Combination; F | 1999 |
Glaucoma Laser Trial reports encouraging early results.
Topics: Argon; Combined Modality Therapy; Epinephrine; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Lase | 1991 |
Impact of intraocular pressure regulation on visual fields in open-angle glaucoma.
Topics: Aged; Aged, 80 and over; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lase | 1999 |
Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
Topics: Aged; Clonidine; Female; Glaucoma, Open-Angle; Humans; Incidence; Intraocular Pressure; Laser Therap | 1999 |
Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension.
Topics: Aged; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Glaucoma, | 1999 |
Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
Topics: Adjuvants, Pharmaceutic; Carbonic Anhydrase Inhibitors; Double-Blind Method; Female; Glaucoma, Open- | 1999 |
The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
Topics: Activities of Daily Living; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic An | 1999 |
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug T | 2000 |
The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Drug Administra | 2000 |
Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
Topics: Aged; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Drug Administration Schedule; F | 2001 |
Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. A controlled multicenter study of 48 weeks. Scandinavian Timpilo Study Group.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Drug Combinations; Female; Glaucoma, Open-Angle; Hu | 1992 |
Primary argon laser trabeculoplasty vs. pilocarpine. Short-term effects.
Topics: Follow-Up Studies; Glaucoma, Neovascular; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser | 1992 |
Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.
Topics: Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Pilocarpine; | 1992 |
Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.
Topics: Absorption; Carbachol; Chronic Disease; Cornea; Dose-Response Relationship, Drug; Double-Blind Metho | 1992 |
Long-term treatment with Pilogel/beta-blocker in glaucoma patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Therapy, Co | 1991 |
Occurrence of disc haemorrhages in open-angle glaucoma treated with pilocarpine or timolol.
Topics: Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Incidence; Intraocular Pressure; Male | 1991 |
A prospective study of oral Nadolol in the management of patients with newly diagnosed chronic simple glaucoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Chronic Disease; Female; Glaucoma, Open-Angle; Humans | 1991 |
The combined use of apraclonidine and pilocarpine during laser iridotomy in a Hispanic population.
Topics: Aged; Clonidine; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Gl | 1990 |
[Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
Topics: Carbonic Anhydrase Inhibitors; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertensi | 1990 |
Twelve-hour IOP control obtained by a single dose of timolol/pilocarpine combination eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Dru | 1990 |
[Clinical trial of Pilogel HS made by Alcon].
Topics: Aged; Clinical Trials as Topic; Female; Gels; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Piloc | 1990 |
[Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
Topics: Aged; Double-Blind Method; Drug Combinations; Drug Evaluation; Female; Glaucoma, Open-Angle; Humans; | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
Topics: Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle | 1990 |
Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Circadian Rhythm; Clinical Trials as Topic; Drug Thera | 1989 |
Timolol-pilocarpine combined vs timolol and pilocarpine given separately.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; I | 1989 |
Epidemiologic approach to open-angle glaucoma: 2. Survival analysis of adverse drug reactions. Report of the Canadian Ocular Adverse Drug Reaction Registry Program. The Collaborative Glaucoma Study Group.
Topics: Acetazolamide; Adult; Age Factors; Aged; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angl | 1989 |
Laser trabeculoplasty versus medication treatment as primary therapy for glaucoma.
Topics: Acetazolamide; Clinical Trials as Topic; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocula | 1989 |
[Metipranolol 0.1% and pilocarpine 2% as a fixed combination compared to each substance alone in the treatment of glaucoma. A controlled, randomized clinical study comparing the intraindividual effects and tolerance].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Press | 1986 |
Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; H | 1987 |
A comparative evaluation of timolol maleate and pilocarpine in the treatment of chronic open angle glaucoma.
Topics: Aged; Clinical Trials as Topic; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Pilocarpine | 1988 |
The Lang lecture 1986. The enigma of primary open-angle glaucoma.
Topics: Adult; Aged; Clinical Trials as Topic; Epinephrine; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 1986 |
Control of chronic simple glaucoma with primary medical, surgical and laser treatment.
Topics: Clinical Trials as Topic; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Pilocar | 1986 |
A double-masked study of timolol and pilocarpine combined.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Glau | 1987 |
Timolol/pilocarpine combination eye drops in open angle glaucoma and in ocular hypertension. A controlled randomized study.
Topics: Aged; Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Middle Aged | 1987 |
[The effect of timolol/pilocarpine combinations with a fixed ratio compared with 0.5% timolol in the treatment of open-angle glaucoma].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Male; Midd | 1988 |
A dose-response study of piloplex for duration of action.
Topics: Adult; Dose-Response Relationship, Drug; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Pilocar | 1985 |
Primary therapy for chronic simple glaucoma the role of argon laser trabeculoplasty.
Topics: Aged; Chronic Disease; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Methods; M | 1985 |
98 other studies available for pilocarpine and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Mechanism for Altered Dark-Adapted Electroretinogram Responses in DBA/2J Mice Includes Pupil Dilation Deficits.
Topics: Animals; Disease Models, Animal; Electroretinography; Glaucoma; Glaucoma, Open-Angle; Intraocular Pr | 2022 |
Changes to Outflow Structures After Pilocarpine in Primary Open Angle Glaucoma Compared With Healthy Individuals Using Optical Coherence Tomography.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Miosis; Pilocarpine; Tomography, Optic | 2023 |
Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Carbonic Anhy | 2019 |
Urrets- Zavalia Syndrome after glaucoma filtration device implantation.
Topics: Acetazolamide; Aged; Brimonidine Tartrate; Cataract Extraction; Combined Modality Therapy; Drug Resi | 2013 |
Morphological alterations within the peripheral fixation of the iris dilator muscle in eyes with pigmentary glaucoma.
Topics: Accommodation, Ocular; Adolescent; Adult; Aged; Aged, 80 and over; Atropine; Biomarkers; Child; Chil | 2014 |
Combined ab interno trabeculotomy and lens extraction: a novel management option for combined uveitic and chronic narrow angle raised intraocular pressure.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cataract Extraction; Dexamethasone; Female; Follow- | 2016 |
Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration.
Topics: Adult; Anterior Eye Segment; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Femal | 2011 |
Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma, Open-Angle; Huma | 2002 |
[Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma].
Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Female; Gels; Glaucoma, Open-Angle; Humans; In | 2000 |
[On the duration of action and efficacy of pilocarpine on the ocular tonus in simple glaucoma].
Topics: Eye; Glaucoma; Glaucoma, Open-Angle; Humans; Pilocarpine | 1960 |
INDICATIONS FOR OPERATION IN OPEN-ANGLE GLAUCOMA.
Topics: Glaucoma; Glaucoma, Open-Angle; Humans; Pilocarpine; Surgical Procedures, Operative | 1963 |
COMPARISON BETWEEN PILOCARPINE AND ECHOTHIOPHATE FOR CHRONIC SIMPLE GLAUCOMA. A COMPARISON BETWEEN 4 PER CENT PILOCARPINE AND 0.06 PER CENT ECHOTHIOPHATE IODINE IN THE DIURNAL MANAGEMENT OF CHRONIC SIMPLE GLAUCOMA.
Topics: Cholinesterase Inhibitors; Glaucoma; Glaucoma, Open-Angle; Humans; Iodine; Manometry; Ophthalmic Sol | 1964 |
AQUEOUS FLOW MEASUREMENTS IN MAN BY THE PERILIMBAL SUCTION CUP TECHNIQUE. II. COMPARISONS IN CHRONIC SIMPLE GLAUCOMA BEFORE AND AFTER PILOCARPINE.
Topics: Aqueous Humor; Canada; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Pharmacol | 1964 |
Is addition of a third or fourth antiglaucoma medication effective?
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Carbonic Anhydrase | 2004 |
[Ocular hypertension and glaucoma].
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Int | 2005 |
Open-angle glaucoma: diagnosis and management.
Topics: Administration, Topical; Adult; Aqueous Humor; Drug Therapy, Combination; Epinephrine; Glaucoma, Ope | 1983 |
[Drug therapy of chronic glaucoma with pilocarpine gel].
Topics: Acrylic Resins; Adult; Delayed-Action Preparations; Gels; Glaucoma, Open-Angle; Humans; Intraocular | 1984 |
The management of primary open-angle glaucoma.
Topics: Glaucoma, Open-Angle; Humans; Ophthalmic Solutions; Parasympathomimetics; Pilocarpine; Timolol | 1983 |
Drop attack in glaucoma. The Melbourne experience with topical miotics, adrenergic and neuronal blocking drops.
Topics: Echothiophate Iodide; Epinephrine; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mio | 1983 |
Dose response of topical pilocarpine-epinephrine combinations in normotensive and glaucomatous Beagles.
Topics: Animals; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Epinephrine; Femal | 1983 |
Medical management of glaucoma.
Topics: Acetazolamide; Adrenal Cortex Hormones; Epinephrine; Glaucoma; Glaucoma, Open-Angle; Humans; Miotics | 1983 |
Combined timolol and epinephrine therapy for open angle glaucoma.
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Pilocarp | 1983 |
[Long-term therapy with timolol for three years (author's transl)].
Topics: Acetazolamide; Carbachol; Drug Therapy, Combination; Glaucoma; Glaucoma, Open-Angle; Humans; Intraoc | 1981 |
Visual ability and drug regimen: relation to compliance with glaucoma therapy.
Topics: Aged; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Complia | 1983 |
Ocular hypotensive action of labetalol in rabbit and human eyes.
Topics: Animals; Dose-Response Relationship, Drug; Ethanolamines; Female; Glaucoma, Open-Angle; Humans; Intr | 1981 |
The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.
Topics: Acetazolamide; Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Finland; Glaucoma; Glauc | 1982 |
Metoprolol eyedrops 3%, a short-term comparison with pilocarpine and a five-month follow-up study. (Multicenter).
Topics: Adult; Aged; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Me | 1982 |
[The effect of high-percent pilocarpine in the pigmented eye].
Topics: Adult; Aged; Black People; Drug Administration Schedule; Eye Color; Female; Glaucoma, Open-Angle; Hu | 1982 |
Medication versus surgery: are we doing it wrong?
Topics: Glaucoma, Open-Angle; Humans; Pilocarpine; Timolol; Trabecular Meshwork | 1981 |
Comparative study of aqueous and oily pilocarpine in the production of ocular hypotension.
Topics: Aged; Drug Administration Schedule; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; | 1981 |
[Pilocarpine, carbachol and carteolol on open-angle glaucoma and ocular hypertension (author's transl)].
Topics: Adolescent; Adult; Aged; Carbachol; Carteolol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pre | 1981 |
[Pilocarpine test and the dynamics of daily intraocular pressure fluctuations in open-angle glaucoma].
Topics: Aged; Circadian Rhythm; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Pilocarpin | 1981 |
The case against treating glaucoma.
Topics: Adrenergic beta-Antagonists; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Miotics; Ophthalmic | 1995 |
Lichen planus associated with topical beta-blocker therapy.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Biopsy; Drug Therapy, Combination; Female; Gla | 1995 |
Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antigens, CD; Complement C3b; Conjunctiva; Epithel | 1995 |
Clinical experience with a fixed dose combination therapy of timolol and pilocarpine used twice daily in the management of chronic open angle glaucoma.
Topics: Aged; Aged, 80 and over; Chronic Disease; Drug Administration Schedule; Drug Combinations; Female; G | 1994 |
Lens opacity in unilateral exfoliation syndrome with or without glaucoma.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Cataract; Exfoliation Syndrome; Glaucoma, Open-Angle; Hum | 1994 |
Ultrasound biomicroscopy in pigment dispersion syndrome.
Topics: Adolescent; Adult; Anterior Eye Segment; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; | 1994 |
Visual field prognosis in early glaucoma. A long-term clinical follow-up.
Topics: Acetazolamide; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Longitudinal S | 1993 |
Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma.
Topics: Chronic Disease; Drug Combinations; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Ophthal | 1993 |
The effect of topical pilocarpine on pulsatile ocular blood flow.
Topics: Administration, Topical; Aged; Drug Therapy, Combination; Eye; Glaucoma, Open-Angle; Humans; Middle | 1993 |
Patient selection in the Timpilo Study.
Topics: Chronic Disease; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Opht | 1993 |
The effect of pilocarpine on the glaucomatous visual field.
Topics: Aged; Aged, 80 and over; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; M | 1993 |
Clinical analysis of steroid glaucoma.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Dexamethasone; Female; Follow | 1995 |
Cardiac failure aggravated by timolol eye drops: preoperative improvement by changing to pilocarpine.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Bradycardia; Cardiac Output, Low; Female | 1996 |
The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Che | 1996 |
The effects of nasolacrimal canal blockage on topical medications for glaucoma.
Topics: Absorption; Administration, Topical; Adrenergic Agonists; Adrenergic beta-Antagonists; Adult; Aged; | 1996 |
Systemic pilocarpine toxicity from Ocusert leakage.
Topics: Adolescent; Dizziness; Drug Delivery Systems; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ma | 1996 |
Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Dog Diseases; Dogs; Dose-Response Rel | 1995 |
Ocular hypotensive effect of pilocarpine before and after argon laser trabeculoplasty.
Topics: Aged; Aged, 80 and over; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure | 1997 |
Primary argon laser trabeculoplasty vs pilocarpine 2% in primary open angle glaucoma: two years follow-up study.
Topics: Administration, Topical; Adult; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular | 1997 |
Scanning laser polarimetry of the retinal nerve fibre layer in primary open angle and capsular glaucoma.
Topics: Aged; Analysis of Variance; Case-Control Studies; Female; Glaucoma, Open-Angle; Humans; Male; Micros | 1997 |
Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility.
Topics: Administration, Topical; Aged; Carbonic Anhydrase Inhibitors; Cell Count; Chronic Disease; Cornea; D | 1998 |
Temporal filter of the motion sensor in glaucoma.
Topics: Adult; Aged; Glaucoma, Open-Angle; Humans; Middle Aged; Miotics; Motion Perception; Pilocarpine; Reg | 1997 |
Ocular tension and pupil diameter effects of timolol 0.50% and pilocarpine 2% or 4% in association.
Topics: Adrenergic beta-Antagonists; Aged; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Stu | 1997 |
[Tearing in a patient with glaucoma].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Chronic Disease; Female; Glaucoma, Open-Angle | 1998 |
The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Clonidine; Female | 1998 |
Prevalence and management of elevated intraocular pressure in patients with Graves' orbitopathy.
Topics: Adult; Aged; Antihypertensive Agents; Decompression, Surgical; Female; Glaucoma, Open-Angle; Graves | 1998 |
Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response.
Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Conjunctiva; Drug Therapy, Combination; Follow- | 1998 |
Red blood cell membrane integrity in primary open angle glaucoma: ex vivo and in vitro studies.
Topics: Acetylcholinesterase; Adrenergic beta-Antagonists; Aged; Erythrocyte Membrane; Female; Glaucoma, Ope | 1999 |
Marfan syndrome, lens subluxation, and open-angle glaucoma.
Topics: Acetazolamide; Adult; Cataract Extraction; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; | 1999 |
[Erosive marginal keratitis due to pilocarpine allergy].
Topics: Aged; Corneal Ulcer; Drug Hypersensitivity; Female; Glaucoma, Open-Angle; Humans; Middle Aged; Mioti | 1999 |
[A myopia study of glaucoma patients following pilocarpine instillation].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Male; Middle | 2000 |
Beta-adrenergic blocker therapy and the trabecular meshwork.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aqueous Humor; Drug Therapy, Co | 2001 |
[Additive effects of topical carbonic anhydrase inhibitors].
Topics: Aged; Betaxolol; Carbonic Anhydrase Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; G | 2001 |
"Masked" pseudoexfoliation syndrome in unoperated eyes with circular posterior synechiae: clinical-electron microscopic correlation.
Topics: Aged; Aged, 80 and over; Carbachol; Cataract Extraction; Cross-Sectional Studies; Exfoliation Syndro | 2001 |
Reversal of poorly controlled glaucoma on diagnosis and treatment of hypothyroidism.
Topics: Female; Fundus Oculi; Glaucoma, Open-Angle; Hemorrhage; Humans; Hypothyroidism; Intraocular Pressure | 1992 |
Effects of pupillary dilation on automated perimetry in glaucoma patients receiving pilocarpine.
Topics: Adult; Aged; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Phenylephrine; Pilocarpine; Pu | 1992 |
Side effects of topical treatment in pigmentary glaucoma.
Topics: Administration, Topical; Adult; Aged; Drug Therapy, Combination; Epinephrine; Female; Follow-Up Stud | 1992 |
Conjunctival impression cytology in patients with glaucoma using long-term topical medication.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Conjunctiva; Conjunctival Diseases; Drug | 1991 |
Intraocular pressure response to the replacement of pilocarpine or carbachol with echothiophate.
Topics: Aphakia; Aphakia, Postcataract; Carbachol; Echothiophate Iodide; Female; Follow-Up Studies; Glaucoma | 1991 |
Glaucoma and Peters' anomaly. A clinicopathologic case report.
Topics: Adult; Anterior Chamber; Collagen; Cornea; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressur | 1991 |
Rhegmatogenous retinal detachment after initiation of ocusert therapy.
Topics: Adult; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Pilocarpine; Retinal Detachment; Ri | 1991 |
[The influence of miosis on the central visual field].
Topics: Adult; Aged; Glaucoma, Open-Angle; Humans; Middle Aged; Miotics; Pilocarpine; Pupil; Visual Fields | 1990 |
The progress of the visual field in chronic simple glaucoma and ocular hypertension treated topically with pilocarpine or with timolol.
Topics: Administration, Topical; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Male; Ocular Hyperte | 1990 |
The role of apraclonidine hydrochloride in laser therapy for glaucoma.
Topics: Acetazolamide; Adult; Aged; Animals; Clonidine; Epinephrine; Female; Glaucoma, Open-Angle; Humans; I | 1989 |
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Hu | 1989 |
Effects of 4% pilocarpine gel on normotensive and glaucomatous canine eyes.
Topics: Animals; Dog Diseases; Dogs; Female; Glaucoma, Open-Angle; Intraocular Pressure; Male; Pilocarpine; | 1989 |
Long-term results of 5-fluorouracil trabeculectomy for primary open-angle glaucoma.
Topics: Adult; Aged; Epinephrine; Female; Fluorouracil; Glaucoma, Open-Angle; Humans; Injections; Intraocula | 1989 |
[Dynamics of visual function in glaucoma patients treated with various antiglaucoma preparations].
Topics: Aged; Drug Evaluation; Drug Therapy, Combination; Epinephrine; Female; Glaucoma, Open-Angle; Humans; | 1989 |
Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%.
Topics: Aged; Chronic Disease; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle | 1989 |
[Studies on ding gong teng in lowering of intraocular pressure and miosis].
Topics: Adolescent; Adult; Aged; Alkaloids; Animals; Cyclic GMP; Depression, Chemical; Double-Blind Method; | 1986 |
[The effect of long-term administration of beta blockers and pilocarpine on the permeability of blood vessels in the iris as seen in fluoroangiography].
Topics: Adult; Aged; Capillary Permeability; Female; Fluorescein Angiography; Glaucoma, Open-Angle; Humans; | 1985 |
Glaucoma.
Topics: Adrenergic beta-Antagonists; Betaxolol; Glaucoma; Glaucoma, Open-Angle; Humans; Infant, Newborn; Las | 1987 |
Intraocular pressure response to replacing pilocarpine with carbachol.
Topics: Aged; Carbachol; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; | 1988 |
[Coexistence of retinal detachment and primary open-angle glaucoma].
Topics: Female; Glaucoma, Open-Angle; Humans; Middle Aged; Pilocarpine; Retinal Detachment; Scleral Buckling | 1988 |
Cholinergic supersensitivity of the iris in primary open angle glaucoma. A clinical study.
Topics: Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Iris; Male; Middle Aged; Pilocarpine; | 1988 |
[Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
Topics: Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Guanethidine; Humans; Intraocular Pres | 1987 |
Interaction of dipivefrin and epinephrine with the pilocarpine ocular therapeutic system (Ocusert)
Topics: Adult; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Epinephrine; Glauc | 1986 |
[Changes in the concentration of pilocarpine eyedrops in normal storage].
Topics: Accommodation, Ocular; Dose-Response Relationship, Drug; Drug Storage; Glaucoma, Open-Angle; Humans; | 1986 |
The detection and management of the acute rise in intraocular pressure following laser trabeculoplasty.
Topics: Forecasting; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Pilocarpine; Postope | 1986 |
Severe symptomatic atrioventricular block induced by pilocarpine eye drops.
Topics: Aged; Electrocardiography; Glaucoma, Open-Angle; Heart Block; Humans; Male; Ophthalmic Solutions; Pi | 1987 |
Corneal changes during pilocarpine gel therapy.
Topics: Conjunctiva; Cornea; Corneal Opacity; Follow-Up Studies; Gels; Glaucoma, Open-Angle; Humans; Keratit | 1986 |
Open angle glaucoma in melanosis oculi: response to laser trabeculoplasty.
Topics: Adolescent; Eye Diseases; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Laser Ther | 1985 |
Progression of visual field defects in glaucoma. Relation to compliance with pilocarpine therapy.
Topics: Glaucoma, Open-Angle; Humans; Patient Compliance; Pilocarpine; Visual Fields | 1985 |
Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium: YAG laser posterior capsulotomy.
Topics: Cataract Extraction; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Lens Capsule | 1985 |
[Comparative studies of pilocarpine gel and pilocarpine eyedrops].
Topics: Accommodation, Ocular; Adult; Aged; Dark Adaptation; Female; Gels; Glaucoma, Open-Angle; Humans; Int | 1985 |
The efficacy of combinations of ocular hypotensive drugs. A tonographic approach.
Topics: Drug Evaluation; Drug Therapy, Combination; Echothiophate Iodide; Epinephrine; Female; Glaucoma, Ope | 1967 |